TMPRSS2 and severe acute respiratory syndrome: For instance, with HeLa cells expressing ACE2, the effect of camostat mesylate was negligible in inhibiting SARS-CoV infection compared to its effect on the same cells engineered to overexpress TMPRSS2 [28].